ConductScience.org, home

Paper8156972

Topiramate: preclinical evaluation of structurally novel anticonvulsant.

Shank RP and 8 others. Epilepsia, 1994. Cited by 294 papers, by iCite.

Cite this record

ConductScience Library. Topiramate: preclinical evaluation of structurally novel anticonvulsant. Papers, record 8156972. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8156972

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Topiramate: preclinical evaluation of structurally novel anticonvulsant.
PubMed
Journal
Epilepsia
PubMed
Year
1994
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
294
iCite
Relative citation ratio, by iCite
10.9
iCite
Revised in PubMed
2026-01-28
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shank RPR P
2Gardocki JFJ F
3Vaught JLJ L
4Davis CBC B
5Schupsky JJJ J
6Raffa RBR B
7Dodgson SJS J
8Nortey SOS O
9Maryanoff BEB E

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AnticonvulsantsMajor topic
FructoseMajor topic
SeizuresMajor topic
Animals
Drug Interactions
Electroshock
Male
Mice
Molecular Structure
Pentylenetetrazole
Picrotoxin
Rats
Rats, Wistar
Reserpine
Tetrabenazine
Topiramate

Source PubMed

Download CSV of topics

Cited by54

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 294 citations.

PMIDTitleJournalYearIn PapersSource
42942813Progress in Anti-Obesity Drug Development: A Pharmacodynamics Perspective.Pharmaceutics2026https://conductscience.org/library/papers/42942813PubMed
42774767Functional and pharmacological characterization of the SCN2A variant p.C258R with mixed gain and loss of function causing developmental and epileptic encephalopathy type 11.Epilepsy Behav Rep2026https://conductscience.org/library/papers/42774767PubMed
42062764Applications of Carbonic Anhydrase Inhibitors in Neurological Disorders, Mechanisms and Therapeutic Potential.Subcell Biochem2026https://conductscience.org/library/papers/42062764PubMed
40036256Evaluation of caffeine modulation of topiramate effect on locomotor activity of zebrafish larvae in pentylenetetrazol-induced seizure model.PLoS One2025https://conductscience.org/library/papers/40036256PubMed
38967655Persistent sodium currents in neurons: potential mechanisms and pharmacological blockers.Pflugers Arch2024https://conductscience.org/library/papers/38967655PubMed
37593583Recent advancements in pharmacological strategies to modulate energy balance for combating obesity.RSC Med Chem2023https://conductscience.org/library/papers/37593583PubMed
37368102Narrative Review of Topiramate: Clinical Uses and Pharmacological Considerations.Adv Ther2023https://conductscience.org/library/papers/37368102PubMed
36582062Antiseizure Medications for the Prophylaxis of Migraine during the Anti- CGRP Drugs Era.Curr Neuropharmacol2023https://conductscience.org/library/papers/36582062PubMed
36569331Zebrafish EEG predicts the efficacy of antiepileptic drugs.Front Pharmacol2022https://conductscience.org/library/papers/36569331PubMed
36073149Anti-obesity carbonic anhydrase inhibitors: challenges and opportunities.J Enzyme Inhib Med Chem2022https://conductscience.org/library/papers/36073149PubMed
35910324Topiramate in an Experimental Model of Epilepsy - Similarity between Generic, Similar and Reference Drugs.J Epilepsy Res2022https://conductscience.org/library/papers/35910324PubMed
35625928Alcohol Use Disorder: Neurobiology and Therapeutics.Biomedicines2022https://conductscience.org/library/papers/35625928PubMed
34770789Carbonic Anhydrase Inhibitors and Epilepsy: State of the Art and Future Perspectives.Molecules2021https://conductscience.org/library/papers/34770789PubMed
34226984Anticonvulsant Effects of Carbonic Anhydrase Inhibitors: The Enigmatic Link Between Carbonic Anhydrases and Electrical Activity of the Brain.Neurochem Res2021https://conductscience.org/library/papers/34226984PubMed
33388905Synchronous neuronal interactions in rat hypothalamic culture: a novel model for the study of network dynamics in metabolic disorders.Exp Brain Res2021https://conductscience.org/library/papers/33388905PubMed
33202963Insights into Potential Targets for Therapeutic Intervention in Epilepsy.Int J Mol Sci2020https://conductscience.org/library/papers/33202963PubMed
27050163Knockdown of Carboxypeptidase A6 in Zebrafish Larvae Reduces Response to Seizure-Inducing Drugs and Causes Changes in the Level of mRNAs Encoding Signaling Molecules.PLoS One2016https://conductscience.org/library/papers/27050163PubMed
26467409Pharmacological Approaches for Treatment-resistant Bipolar Disorder.Curr Neuropharmacol2015https://conductscience.org/library/papers/26467409PubMed
25625090A muliticenter retrospective study of the actual using patterns and clinical effects of topiramate in patients with neurosurgical disease.J Epilepsy Res2014https://conductscience.org/library/papers/25625090PubMed
25616473Current understanding of the mechanism of action of the antiepileptic drug lacosamide.Epilepsy Res2015https://conductscience.org/library/papers/25616473PubMed

See all 54 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8156972

GET https://conductscience.org/api/papers/v1/8156972/cited_by?page=2